loading page

Cold agglutinin disease following SARS-CoV-2 and Mycoplasma pneumoniae co-infections
  • +6
  • Chatphatai MoonlaOrcid,
  • Phandee Watanaboonyongcharoen,
  • Gompol Suwanpimolkul,
  • Leilani Paitoonpong,
  • Watsamon Jantarabenjakul,
  • Chantiya Chanswangphuwana,
  • Chantana Polprasert,
  • Ponlapat Rojnuckarin,
  • Opass Putcharoen
Chatphatai Moonla
Orcid
Chulalongkorn University Faculty of Medicine
Author Profile
Phandee Watanaboonyongcharoen
Chulalongkorn University Faculty of Medicine
Author Profile
Gompol Suwanpimolkul
Chulalongkorn University Faculty of Medicine
Author Profile
Leilani Paitoonpong
Chulalongkorn University Faculty of Medicine
Author Profile
Watsamon Jantarabenjakul
Chulalongkorn University Faculty of Medicine
Author Profile
Chantiya Chanswangphuwana
Chulalongkorn University Faculty of Medicine
Author Profile
Chantana Polprasert
Chulalongkorn University Faculty of Medicine
Author Profile
Ponlapat Rojnuckarin
Chulalongkorn University Faculty of Medicine
Author Profile
Opass Putcharoen
Chulalongkorn University Faculty of Medicine
Author Profile

Peer review status:ACCEPTED

12 May 2020Submitted to Clinical Case Reports
13 May 2020Submission Checks Completed
13 May 2020Assigned to Editor
19 May 2020Reviewer(s) Assigned
26 May 2020Review(s) Completed, Editorial Evaluation Pending
09 Jun 20201st Revision Received
12 Jun 2020Submission Checks Completed
12 Jun 2020Assigned to Editor
17 Jun 2020Review(s) Completed, Editorial Evaluation Pending
21 Jun 2020Editorial Decision: Accept

Abstract

During coronavirus disease 2019 (COVID-19) pandemic, coinfections with other viral infections are not uncommon, but concomitant atypical bacteria are rare. Herein, we describe a young female COVID-19 patient who developed acute cold agglutinin disease secondary to Mycoplasma pneumoniae. Using an azithromycin-containing COVID-19 therapeutic regimen, both pneumonia and anemia resolved uneventfully.